Zylastxp Antiseptic
NDC Package 57362-464-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Zylastxp Antiseptic is handwash to decrease bacteria on the skin that potentially can cause disease. Marketed by Innovative Biodefense, this product is identified by NDC 57362-464 and is authorized under FDA application part333E.

Identification & Billing

NDC Package Code
57362-464-00
Package Description
192.3 mg in 1 BOTTLE, PLASTIC
Product Code
57362-464
11-Digit Billing Format
57362046400
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zylastxp Antiseptic
Dosage Form
-
Usage Information
Handwash to decrease bacteria on the skin that potentially can cause disease. Recommended for repeated use.

Regulatory & Marketing

Labeler Name
Innovative Biodefense
FDA Application #
part333E
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
04-24-2015
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57362-464-00 identifies a specific commercial package of 192.3 mg in 1 bottle, plastic of Zylastxp Antiseptic, labeled by Innovative Biodefense. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Innovative Biodefense on April 24, 2015. The current certification is valid through December 31, 2022.

How is this Innovative Biodefense product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57362046400. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57362-464-00
11-Digit CMS (5-4-2)
57362-0464-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.